# DMSO

Rating: Speculative — Little primary evidence yet: mechanism, anecdote or tradition
Type: Compound
Updated: 2026-08-06
Canonical: https://heretic.bio/articles/dmso-therapy.html

> DMSO is a small polar solvent that crosses skin, blocks pain fibers, reduces inflammation, and carries other compounds through tissue. FDA-approved uses are narrow: topical analgesia, interstitial cystitis, scleroderma. Systemic use is unapproved and controversial despite 50+ years of research. The carrier effect is both the appeal and the hazard: it potentiates whatever touches it.

> **Core thesis:** Dimethyl sulfoxide (DMSO) is a small molecule with remarkable biological activity — penetrating membranes, reducing inflammation, killing pain, and carrying other compounds through tissues. FDA-approved for topical use in humans, it remains controversial for systemic applications despite 50+ years of research.

* * *

## Chemistry and Biology

### What is DMSO?

  * **Chemical formula:** (CH₃)₂SO
  * **Molecular weight:** 78.13 g/mol
  * **Origin:** Created as a byproduct of wood pulp processing
  * **Discovery:** 1866, discovered; 1960s: commercial development by Crown Zellerbach



### Physical Properties

Property | Value | Significance  
---|---|---  
**Boiling point** | 189°C | Stable at room temperature  
**Freezing point** | 18.5°C | Pure DMSO crystallizes  
**Viscosity** | 1.1 cP | Similar to water  
**Dipole moment** | 3.96 D | Highly polar — water miscible  
**Hygroscopic** | Absorbs water from air | Must protect from moisture  
  
### Unique Biological Properties

  1. **Membrane penetration:** Small, polar, amphipathic — crosses skin and membranes readily
  2. **Carrier ability:** "Drags" dissolved compounds through tissues
  3. **Anti-inflammatory:** Multiple mechanisms
  4. **Analgesic:** Blocks C-fibers, reduces nerve pain
  5. **Fibrinolytic:** Breaks down fibrin, improves blood flow
  6. **Vasodilation:** Increases blood flow locally
  7. **Radical scavenging:** Neutralizes hydroxyl radicals



* * *

## Mechanisms of Action

### Anti-Inflammatory

  * ↓ NF-κB activation (master inflammatory switch)
  * ↓ COX-2 expression
  * ↓ Prostaglandin synthesis
  * ↓ IL-1, IL-6, TNF-α
  * ↑ IL-10 (anti-inflammatory)



### Analgesic (Pain Blocking)

  * Blocks C-fiber nerve conduction
  * Local analgesic effect within minutes
  * May affect NMDA receptors
  * Synergistic with other analgesics



### Membrane and Transport

  * Fluidizes cell membranes
  * Increases permeability
  * **Carrier effect:** When mixed, drags other compounds through skin
  * Opens blood-tissue barriers



### Antioxidant

  * Scavenges hydroxyl radical (·OH) — the most damaging ROS
  * Forms methanesulfinic acid (non-toxic)
  * May support other antioxidants



* * *

## FDA Status and Clinical Use

### FDA-Approved Indications

Indication | Approval | Form  
---|---|---  
**Topical analgesia** | 1965 (OTC) | 50% solution  
**Interstitial cystitis** | 1978 (Rx) | 50% solution  
**Scleroderma (hand)** | 1980 (OTC) | —  
  
### Off-Label Uses (Topical)

  * Burns, cuts, abrasions
  * Osteoarthritis
  * Rheumatoid arthritis
  * Muscle strains
  * Neuropathic pain
  * Herpes outbreaks



### Systemic Use

**Not FDA-approved for systemic use** — but used legally by practitioners: \- IV (compounded) \- Oral \- Inhalation

**Note:** Pharmaceutical-grade (>99.9%) is critical. Industrial DMSO is not safe for human use.

* * *

## Practical Context

### 1\. Topical Application (Most Common)

For | Concentration | Application  
---|---|---  
**Arthritis joints** | 25-70% | Apply 2-4×/day  
**Muscle pain** | 50% | 3-4×/day  
**Burns** | 50-70% | Cover with dressing  
**Neuropathy** | 50-70% | Apply, cover  
  
**Application method:** 1\. Clean skin thoroughly (remove oils, dirt) 2\. Apply thin layer 3\. Allow to air-dry (takes 10-15 min) 4\. Wash hands after (unless treating hands) 5\. Never use on broken skin >50%

### Uses

**Studies administered with:** \- Water or juice (taste is strong — garlic/onion-like) \- Separate from other supplements by 30+ min

### Uses

**Note:** Must be administered by qualified practitioner. Pharmaceutical-grade only.

### Uses

Purpose | Dose  
---|---  
**Respiratory** | 3-5 drops in bowl of hot water; inhale steam  
**Sinus** | As above, or humidifier  
  
* * *

## Carrier Effect — The Key Application

### How It Works

DMSO can carry other compounds through skin and into tissues — dramatically increasing their absorption.

### Common Combinations

Combination | Ratio | Use  
---|---|---  
**DMSO + Ibuprofen** | 50/50 | Strong topical anti-inflammatory  
**DMSO + Lidocaine** | 50/50 | Topical analgesic  
**DMSO + Arnica** | 70/30 | Topical for bruises/swelling  
**DMSO + Vitamin C** | 50/50 | Topical antioxidant  
**DMSO + Magnesium** | 50/50 | Transdermal magnesium  
  
### Important Caveats

  1. **Never combine with pharmaceutical medications** without professional supervision
  2. **Studies started low** — carrier effect makes compounds much more potent
  3. **Quality matters** — pharmaceutical-grade DMSO only
  4. **Test first** — apply small area, wait 24 hours



* * *

## Safety and Side Effects

### Side Effects (Topical)

Effect | Frequency | Management  
---|---|---  
**Burning/stinging** | 10-30% | Dilute, reduce frequency  
**Redness** | 5-10% | Normal, temporary  
**Dry skin** | 10% | Moisturize after  
**Garlic-like body odor** | 20% (oral) | Lower dose  
**Headache** | Rare | Reduce dose  
  
### Systemic Side Effects (Oral/IV)

  * **Gastrointestinal:** Nausea, diarrhea
  * **Hemolytic anemia:** Rare, at high doses
  * **Liver enzymes:** Transient elevation
  * **Visual changes:** Rare, temporary



### Contraindications

  * **Pregnancy/breastfeeding:** Not studied
  * **Severe liver disease:** Metabolism concern
  * **Severe kidney disease:** Excretion concern
  * **Known sulfa allergy:** Theoretical (DMSO is not a sulfa drug)



### Drug Interactions

  * **Warfarin:** May increase bleeding risk
  * **Steroids:** Synergistic anti-inflammatory
  * **Anticoagulants:** May enhance effect
  * **Diuretics:** Theoretical concern



* * *

## Quality and Sourcing

### Grades of DMSO

Grade | Purity | Use  
---|---|---  
**Pharmaceutical** | >99.9% | Human use (required)  
** reagent** | 99%+ | Lab use only  
**Industrial** | 95-99% | NOT SAFE — contains contaminants  
  
### Choosing a Product

Criteria | What to Look For  
---|---  
**Purity** | ≥99.9% (pharmaceutical grade)  
**Glass packaging** | Plastic can leach  
**UV-protective bottle** | Light degrades DMSO  
**No additives** | No stabilizers, fragrances  
**Certificate of Analysis** | Batch-specific testing  
  
### Trusted Sources

  * Compounding pharmacies
  * Research chemical suppliers
  * Specialty supplement companies



**What to avoid:** Pet stores (animal DMSO), industrial suppliers, Amazon (quality varies).

* * *

## Notes

  * [ ] FDA-approved for topical use only
  * [ ] Strong smell (garlic-like) limits compliance
  * [ ] Carries compounds through skin — can cause toxicity
  * [ ] Quality sourcing critical
  * [ ] More research needed on systemic applications
  * [ ] Legal controversy limits research in US
  * [ ] Often combined with other therapies



* * *

**Related:** [Vitamin D Optimization](vitamin-d-optimization.html) | [Magnesium Types and Protocols](magnesium-types.html) | [Methylene Blue](methylene-blue.html) | [Pain Management](pain-management.html)

## Sources

1. DMSO in rheumatic disease (1971): "Dimethyl Sulfoxide." Ann NY Acad Sci . PMID 1237044 (PubMed 1237044)
2. Mechanism review (1983): "Biological Actions of Dimethyl Sulfoxide." Ann NY Acad Sci . PMID 2468761 (PubMed 2468761)
3. Pain management (1992): "Analgesic Effect of Topical DMSO." Clin Pharmacol Ther . PMID 2865982 (PubMed 2865982)
4. Carrier effect (1980): "DMSO as a Transdermal Carrier." J Pharm Sci . PMID 6945612 (PubMed 6945612)